Douglas A. Mata

Douglas A. Mata

Harvard University

H-index: 21

North America-United States

About Douglas A. Mata

Douglas A. Mata, With an exceptional h-index of 21 and a recent h-index of 18 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Andrology, Biostatistics, Epidemiology and Public Health, Medical Education, Pathology.

His recent articles reflect a diverse array of research interests and contributions to the field:

GLI1-Altered Mesenchymal Tumors With ACTB or PTCH1 Fusion: A Molecular and Clinicopathologic Analysis

Microsatellite instability and mismatch repair deficiency define a distinct subset of lung cancers characterized by smoking exposure, high tumor mutational burden, and …

POLE variant phenotypic classification to enable identification of patients with colorectal cancer (CRC) who may benefit from immune checkpoint inhibition (ICI).

Liquid biopsy‐based circulating tumour (ct) DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results

Putting comprehensive genomic profiling of ctDNA to work: 10 proposed use cases

Precision needle-punch tumor enrichment from paraffin blocks improves the detection of clinically actionable genomic alterations and biomarkers

Pan-cancer Genomic Analysis of AXL Mutations Reveals a Novel, Recurrent, Functionally Activating AXL W451C Alteration Specific to Myxofibrosarcoma

A Drosophila model of chemotherapy-related cognitive impairment

Douglas A. Mata Information

University

Position

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School

Citations(all)

7182

Citations(since 2020)

5980

Cited By

3299

hIndex(all)

21

hIndex(since 2020)

18

i10Index(all)

41

i10Index(since 2020)

35

Email

University Profile Page

Harvard University

Google Scholar

View Google Scholar Profile

Douglas A. Mata Skills & Research Interests

Andrology

Biostatistics

Epidemiology and Public Health

Medical Education

Pathology

Top articles of Douglas A. Mata

Title

Journal

Author(s)

Publication Date

GLI1-Altered Mesenchymal Tumors With ACTB or PTCH1 Fusion: A Molecular and Clinicopathologic Analysis

Modern Pathology

Darcy A Kerr

Jeffrey M Cloutier

Matthew Margolis

Douglas A Mata

Nathalie J Rodrigues Simoes

...

2024/2/1

Microsatellite instability and mismatch repair deficiency define a distinct subset of lung cancers characterized by smoking exposure, high tumor mutational burden, and …

Journal of Thoracic Oncology

Soo-Ryum Yang

Erika Gedvilaite

Ryan Ptashkin

Jason Chang

John Ziegler

...

2024/3/1

POLE variant phenotypic classification to enable identification of patients with colorectal cancer (CRC) who may benefit from immune checkpoint inhibition (ICI).

Rachel Beth Keller

Zoe Fleischmann

Smruthy Sivakumar

Radwa Sharaf

Tyler Janovitz

...

2024/1/20

Liquid biopsy‐based circulating tumour (ct) DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results

Histopathology

Douglas A Mata

Jessica K Lee

Vignesh Shanmugam

Chelsea B Marcus

Alexa B Schrock

...

2024/2/29

Putting comprehensive genomic profiling of ctDNA to work: 10 proposed use cases

Aakash Desai

Lincoln W Pasquina

Candice Nulsen

Rachel B Keller-Evans

Douglas A Mata

...

2024/1/17

Precision needle-punch tumor enrichment from paraffin blocks improves the detection of clinically actionable genomic alterations and biomarkers

Frontiers in Oncology

Douglas I Lin

Richard SP Huang

Ioannis Ladas

Rachel B Keller

Nimesh R Patel

...

2024/2/20

Pan-cancer Genomic Analysis of AXL Mutations Reveals a Novel, Recurrent, Functionally Activating AXL W451C Alteration Specific to Myxofibrosarcoma

The American Journal of Surgical Pathology

Erik A Williams

Isabella Vegas

Fardous F El-Senduny

Jessica Zhang

Douglas A Mata

...

2024/2/19

A Drosophila model of chemotherapy-related cognitive impairment

bioRxiv

Matthew Torre

Hassan Bukhari

Vanitha Nithianandam

Camila A Zanella

Douglas A Mata

...

2023/6/5

PATH-02. NOVEL SOX10 INDEL MUTATIONS DRIVE SCHWANNOMAS THROUGH IMPAIRED TRANSACTIVATION OF MYELINATION GENE PROGRAMS

Neuro-Oncology

Erik Williams

Ajay Ravindranathan

Rohit Gupta

Nicholas Stevers

Abigail Suwala

...

2023/11/1

Method of tissue acquisition affects success of comprehensive genomic profiling in lung cancer

Archives of Pathology & Laboratory Medicine

Douglas A Mata

Lukas Harries

Erik A Williams

Matthew C Hiemenz

Brennan Decker

...

2023/3/1

Comparing Follicular Extension Between Low-Grade and High-Grade Dysplastic Nevi

The American Journal of Dermatopathology

Vanden L Grube

Shanthi Narla

Douglas A Mata

Farhaan Hafeez

2023/6/1

P1. 21-12 Microsatellite Instability Defines a Subset of Lung Cancers with Smoking Exposure, High Tumor Mutational Burden and MLH1 Inactivation

Journal of Thoracic Oncology

S-R Yang

E Gedvilaite

R Ptashkin

J Chang

J Ziegler

...

2023/11/1

Determining the Association Between Melanomas and Fields of Melanocytic Dysplasia

The American Journal of Dermatopathology

Douglas A Mata

Christine G Lian

Farhaan Hafeez

2023/2/1

Clear cell mesotheliomas with inactivating VHL mutations and near‐haploid genomic features

Genes, Chromosomes and Cancer

Michael Michal

Oleksandr Kravtsov

Jeffrey S Ross

Daniela Skanderová

Petr Martínek

...

2023/5

Expanding Our Knowledge of Molecular Pathogenesis in Histiocytoses: Solitary Soft Tissue Histiocytomas in Children With a Novel: CLTC:: SYK: Fusion

The American Journal of Surgical Pathology

Helena M Crowley

Natalia Georgantzoglou

Y Tse Julie

Erik A Williams

Douglas A Mata

...

2023/10/1

Disparities according to genetic ancestry in the use of precision oncology assays

New England Journal of Medicine

Douglas A Mata

Lisa S Rotenstein

Marco A Ramos

Anupam B Jena

2023/1/19

POLE-specific variant classification strategy is critical for identifying patients who may benefit from immunotherapy

Cancer Research

Rachel B Keller

James Haberberger

Tyler Janovitz

Alexa B Schrock

Hanna Tukachinsky

...

2023/4/4

POU2AF3‐rearranged sarcomas: A novel tumor defined by fusions of EWSR1 or FUS to a gene formerly designated COLCA2

Genes, Chromosomes and Cancer

Matthew C Hiemenz

Jaspreet Kaur

Zheng Kuang

Richard SP Huang

Lukas Harries

...

2023/8

Acute myeloid leukemia with mixed phenotype is characterized by stemness transcriptomic signatures and limited lineage plasticity

medRxiv

Pallavi Galera

Deepika Dilip

Andriy Derkach

Alexander Chan

Yanming Zhang

...

2023

Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs

Neuro-oncology

Erik A Williams

Ajay Ravindranathan

Rohit Gupta

Nicholas O Stevers

Abigail K Suwala

...

2023/12/1

See List of Professors in Douglas A. Mata University(Harvard University)

Co-Authors

H-index: 100
Emanuele Di Angelantonio

Emanuele Di Angelantonio

University of Cambridge

H-index: 52
Ranjith Ramasamy

Ranjith Ramasamy

University of Miami

H-index: 42
Srijan Sen

Srijan Sen

University of Michigan-Dearborn

H-index: 37
Michael Peluso

Michael Peluso

University of California, San Francisco

H-index: 25
Narinder Bansal

Narinder Bansal

University of Bristol

academic-engine